A study found a "significant" link between the frequency of chest X-ray referrals and improved survival rates for lung cancer ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...

Study investigators expect that J&J's combo drug can extend overall survival by at least a year over the current standard of ...

Dukhi Hong, 84, has confounded medics to far exceed their six month prognosis following her diagnosis with small cell lung ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

Results from the COCOON study showed that Rybrevant plus Lacluze reduced grade 2 or higher dermatologic events by 50% ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Aline Browning set out to find answers when her father died from lung cancer following a 25-year career at what was once Lackawanna County’s largest employer. “My dad was not ready. He had time,” the ...

In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have discovered a surprising ...

AstraZeneca presented new data on TAGRISSO® (osimertinib) at the European Lung Cancer Congress (ELCC) 2025, reinforcing its ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for predicting the prognosis of ...